Brief: Nektar Therapeutics Announces Proposed Public Offering
20/04/2026 21:14
April 20 (Reuters) - Nektar Therapeutics NKTR.O: NEKTAR THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING NEKTAR THERAPEUTICS - COMMENCES $250 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK NEKTAR THERAPEUTICS - TO USE NET PROCEEDS FOR RESEARCH AND DEVELOPMENT, CLINICAL DEVELOPMENT, AND GENERAL CORPORATE PURPOSES Source text: ID:nPnX7xwPa Further company coverage: NKTR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nektar Therapeutics
See all newsBrief: Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Nektar Therapeutics Rezpegaldesleukin Demonstrates Durability And Deepening Of Response Through One Year Of Treatment
U.S. STOCKS ON THE MOVEx-Microsoft, 3M, Twilio
U.S. STOCKS ON THE MOVEx-Microsoft, Nike, Nektar Therapeutics
Eli Lilly owes Nektar $90 mln in drug collaboration dispute, US jury says